ID   WAe001-A-1S
AC   CVCL_C9JQ
SY   hESC-MB-/-#1; MB-/-#1; KAIMRCe002-A-1S
DR   BioSamples; SAMEA112769105
DR   hPSCreg; WAe001-A-1S
DR   Wikidata; Q123033807
RX   PubMed=37406498;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6915; MB.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37406498; DOI=10.1016/j.scr.2023.103158;
RA   Alowaysi M., Al-Shehri M., Baadhaim M., AlZahrani H., Aboalola D.,
RA   Daghestani M., Hashem H., Aljahdali R., Salem R., Alharbi A.,
RA   Muharraq M., AlGhamdi K., Alsobiy F., Zia A., Lehmann R., Tegner J.,
RA   Alsayegh K.N.;
RT   "Generation of myoglobin (MB)-knockout human embryonic stem cell
RT   (hESC) line (KAIMRCe002-A-1S) using CRISPR/Cas9 technology.";
RL   Stem Cell Res. 71:103158-103158(2023).
//